‘Shrooms for the Blues: Psilocybin to alleviate difficult-to-treat depression
Journal of High School Science August 25, 2022 Zoe Graham
Psilocybin, the prodrug in psychedelic mushrooms, shows promise as an antidepressant for treatment-resistant and cancer-related depression. Unlike conventional antidepressants, it interacts with the serotonin system to produce positive and enduring mood effects. Clinical trials indicate the drug is safe, especially in small clinical doses, and has led to previously unreachable successes for patients with these difficult-to-treat forms of depression.